Channel 7 News have reported cord blood-derived cells are being used in a world first clinical trial to treat COVID-19.
Monash University and Monash Health are undertaking the trial for severe COVID-19 patients who are anticipated to improve within 24 hours of cord blood treatment.
The impact of COVID-19 is being felt worldwide and there is a tremendous amount of research being undertaken to understand this disease, prevent its transmission, and treat those infected. Patients with COVID-19 can present with little to no symptoms, cold or flu like symptoms, or in severe cases, can progress to pneumonia, sometimes leading to death.
As the potential consequences of the coronavirus (COVID-19) are felt across many aspects of our lives, we’re reaching out to update our client families. We want to anticipate potential questions regarding the impact of the virus on cord blood collection, storage and therapeutic use.
You’ve nurtured and prepared your children to be happy and healthy adults. Now they’re grown up with children of their own arriving, there’s different, long lasting support you can provide.
There have been some exciting developments in a clinical trial investigating expanded cord blood for the treatment of malignancies.
Australian pre-clinical research has established through trials on mice that systematic administration of placental stem cells, after ischaemic stroke, stimulates significant neuroprotection and facilitates brain recovery and repair.
This collaborative cord blood stem cell research will assist the determination of the safety and feasibility of injections of autologous umbilical cord blood stem cells into the right ventricle of children with Hypoplastic Left Heart Syndrome ...
Cord blood expansion focuses on the ability to expand the number of cells derived from a cord blood collection. An expanded cord blood unit can further boost utility in both current and future medical uses...
Cell Care, Australia’s largest cord blood & tissue bank has announced it has acquired Insception Lifebank, Canada’s largest private cord blood & tissue bank. The combined entity creates one of the world’s top 10 companies in the sector.